Baxter Infusion Pump Recall: Pump Failure Could Result in Death

Baxter Colleague Infusion pumps, which are widely used at hospitals throughout the United States to deliver IV fluids and medicine, have been recalled by the FDA because the devices could delay or interrupt the infusion of fluids, potentially resulting in serious personal injury or death.

The Baxter infusion pump recall applies to about 275,000 of the Colleague Single and Triple Channel Volumetric pumps that were manufactured and sold from February 1997 through December 2008.

Software and battery usage failures could cause the pumps to stop infusing fluids or medications which may be necessary to keep someone alive. There have been serious injuries and deaths associated with the failure of these pumps according to a statement released by Baxter Healthcare Corp.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

While Baxer originally called the action an “Urgent Device Correction” in January 2009, the FDA re-classified it as a Class I recall on March 11, 2009. Class I recalls are the most serious type of recall, used in situations where there is a reasonable probability that the use of a product will cause serious injury or death.

The electronic infusion pumps are used to deliver medications or other fluids in controlled amounts to patients through epidural, intra-arterial (IA), intravenous (IV), and other methods of administration.

The sophisticated devices monitor several sensors, medical-control software and electronics during therapy and automatically sound an alarm and shut down in a potentially harmful situation.

The infusion pump recall applies to all Colleague Volumetric Infusion Pump Mono 2M8151 and 2M8152, CX 2M8161 and 2M 8163 and CXE 2M9161 and 2M9163 model numbers.

The Baxter Colleague Infusion Pumps have not been sold in the United States since 2005, due to battery problems, electronic failures, software glitches and other defects. Although Baxter Healthcare Corp. has attempted to repair and upgrade the defective pumps, problems have continued to occur with the replacements.

Baxter still does not intend to pull the pumps back from hospitals and other customers, indicating that they intend to fix the infusion pump problems in the field.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.